List view / Grid view

Phil Duncanson (AstraZeneca)

 

article

A strategic approach to optimisations of testing bacterial endotoxins

24 August 2022 | By , , ,

Given industry's recent focus on the sustainability of bacterial endotoxin testing (BET), here, AstraZeneca colleagues Miriam Guest, Karen Capper, Dennis Wong and Phil Duncanson share how they worked to establish a short-, mid- and long-term strategy to optimise BET across the global enterprise. They also explore some of the short-term…